Skip to content

Drug interactions

Ergotamine + Zafirlukast

Severity: Moderate

Ergotamine and Zafirlukast: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ergotamine toxicity (ergotism with peripheral ischemia) is a concern with CYP3A4 inhibitors. Zafirlukast is only a weak or in vitro CYP3A4 inhibitor, so the real risk is uncertain but the consequences could be severe.

What this interaction means in plain words

Ergotamine and Zafirlukast can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Ergotamine belongs to Central Nervous System; Zafirlukast belongs to Respiratory.

Evidence level: Low

Why it happens

Possible weak CYP3A4 inhibition by zafirlukast reducing ergotamine clearance.

What to do

Monitor for numbness, tingling, cold extremities, nausea and vasospasm, and stop ergotamine if they appear. Use a triptan or other migraine therapy if concern persists.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ergotamine and Zafirlukast, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ergotamine with Zafirlukast?

MediHelp rates the interaction as moderate. Ergotamine and Zafirlukast can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ergotamine toxicity (ergotism with peripheral ischemia) is a concern with CYP3A4 inhibitors. Zafirlukast is only a weak or in vitro CYP3A4 inhibitor, so the real risk is uncertain but the consequences could be severe.

How serious is the interaction between Ergotamine and Zafirlukast?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for numbness, tingling, cold extremities, nausea and vasospasm, and stop ergotamine if they appear. Use a triptan or other migraine therapy if concern persists.

What other medicines interact with Zafirlukast?

MediHelp also lists interactions of Zafirlukast with, for example, Pimozide, Lomitapide, Nilotinib. The full list is on the Zafirlukast page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in